Abbvie, Inc. (ABBV) Tops Q2 EPS by 13c; Boosts FY13 EPS Midpoint
Abbvie, Inc. (NYSE: ABBV) reported Q2 EPS of $0.92, $0.13 better than the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
